Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ViRexx

2001 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
5 FINANCING ROUNDS
Description

Developer of the novel and unique therapeutic products designed to harness the body's power to cure. The company's focus lies in the development of novel and unique therapeutic products for the treatment of chronic Hepatitis B, Hepatitis C and selected solid tumors in order to enhance the immune system and recognize and remove specific viruses in the body.

Website
Formerly Known As
ViRexx Research
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Acquirer
Former Stock Listing
VIR
Primary Office
  • 8223 Roper Road
  • Edmonton, Alberta T6E 6S4
  • Canada

ViRexx Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ViRexx‘s full profile, request access.

Request full access to PitchBook

ViRexx Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore ViRexx‘s full profile, request access.

Request full access to PitchBook